Employers Push Costs for Health on Workers
Experimental Novartis Drug Shows Malaria Promise
Prescription Drug Use Rose to Include Half of Americans in 2008
THE LATEST WORD
Top Industry Stories – September 3, 2010
Posted on September 3rd, 2010 | by Rxmedyn | No Comments »Posted in Industry Stories
Top Industry Stories – September 2, 2010
Posted on September 2nd, 2010 | by Rxmedyn | No Comments »Child’s Ordeal Shows Risks of Psychosis Drugs for Young
Finding Suggests New Aim for Alzheimer’s Drugs
Diet Drug Meridia Raises Heart Attack, Stroke risk
Diabetes Drug May Keep Lung Cancer at Bay
Posted in Industry Stories
Top Industry Stories -August 31, 2010
Posted on August 31st, 2010 | by Rxmedyn | No Comments »Drug Makers on the Trail of an Alternative to Steroids
US Urges Nearly All to Get Flu Shots
Cough-Syrup Abuse by Kids May Draw FDA Restrictions for Pfizer, J&J Drugs
Glaxo, Valeant May Wait 3 More Months for U.S. FDA to Review Epilepsy Drug
Posted in Industry Stories
Top Industry Stories – August 30, 2010
Posted on August 30th, 2010 | by Rxmedyn | No Comments »High-Deductible Plans Grow, but Not Everyone Should Get on Board
Years Later, No Magic Bullet Against Alzheimer’s Disease
Sanofi Unveils Genzyme ‘Bear Hug’
Potential Cause of Asthma-Like Symptoms Spotted in Mice
Posted in Industry Stories
Top Industry Stories – August 27, 2010
Posted on August 27th, 2010 | by Rxmedyn | No Comments »Estimate Lowered of Typical Flu Toll
Toeing a Thin Line with Foot Surgery
Are Allergies Associated with Heart Disease?
Stallergenes Set to Begin Looking for U.S. Partner, Chief Executive Says
Posted in Industry Stories
Top Industry Stories – August 26, 2010
Posted on August 26th, 2010 | by Rxmedyn | No Comments »Antihistamine Use Linked to Extra Pounds
Sanofi Said To Be Unwilling to Raise Genzyme Bid Price
Patients in Clinical Trials to get Routine Care Covered
US Branded Drug Prices Up 8.3% in Just One Year
Posted in Industry Stories
Top Industry Stories – August 25, 2010
Posted on August 25th, 2010 | by Rxmedyn | No Comments »Stem Cell Ruling will be Appealed
Diabetes Drug Avandia Just as Safe as Actos: Study
Johnson & Johnson gets FDA Warning on Marketing
Foreign Drugmaker Buyouts Raise Concern in India, Financial Express Says
Posted in Industry Stories
Top Industry Stories – August 24, 2010
Posted on August 24th, 2010 | by Rxmedyn | No Comments »U.S. Judge Rules Against Obama’s Stem Cell Policy
Headed to ER? Some Post Waits by Text, Billboard
Vit D Linked to Cancer, Autoimmune Disease Genes
U.S. Probes Egg Recall Amid Calls for Tighter Rules
Roche’s Avastin Again Fails to Win U.K. Panel Backing in Colorectal Cancer
Posted in Industry Stories
Top Industry Stories – August 23, 2010
Posted on August 23rd, 2010 | by Rxmedyn | No Comments »Fixing a World That Fosters Fat
Patients Should Stay on Pfizer’s Lipitor, Not Switch to Generic, Study Say
New Health Plans for Uninsured off to Slow Start
FDA Chief on Salmonella: Agency Needs More Authority
Your Health: Got Allergies? Maybe it’s Actually Non-Allergic Rhinitis
Posted in Industry Stories
Top Industry Stories – August 20, 2010
Posted on August 20th, 2010 | by Rxmedyn | No Comments »Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain
Reanimated ‘Junk’ DNA Is Found to Cause Disease
Glaxo Memo on Avandia Is Questioned
Painkiller Use Linked to Stroke Risk
Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
Careers | © 2009 Medical Dynamics